You have no items in your shopping cart.
Anti-NaPi2b / SLC34A2 Reference Antibody (lifastuzumab vedotin)
Description
Images & Validation
−| Tested Applications | ELISA, FC |
|---|---|
| Reactivity | Human |
Key Properties
−| Antibody Type | Primary Antibody |
|---|---|
| Clonality | Monoclonal |
| Isotype | IgG1 |
| Source/Expression System | CHO Cell |
| Protein Sequence | NaPi2b / SLC34A2 |
| Molecular Weight | 145 Da |
| Endotoxin | < 0.001EU/μg,determined by LAL method. |
| Conjugation | Unconjugated |
Storage & Handling
−| Form/Appearance | Purified monoclonal antibody supplied in PBS, pH 6.0, without preservative.This antibody is purified through a protein A column. |
|---|---|
| Concentration | 1mg/ml |
| Expiration Date | 12 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−
Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

The purity of Anti-NaPi2b / SLC34A2 Reference Antibody (lifastuzumab vedotin) is more than 95%, determined by SEC-HPLC.

Anti-NaPi2b / SLC34A2 Reference Antibody (lifastuzumab vedotin) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%
Quick Database Links
UniProt Details
−Documents Download
Request a Document
Protocol Information
Anti-NaPi2b / SLC34A2 Reference Antibody (lifastuzumab vedotin) (orb1818063)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review